STOCK TITAN

Atomera Inc SEC Filings

ATOM NASDAQ

Welcome to our dedicated page for Atomera SEC filings (Ticker: ATOM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Atomera Incorporated filings document the company's semiconductor technology licensing business, Nasdaq-listed common stock, and material-event disclosures. Current reports furnish quarterly and annual financial results, investor presentations, Regulation FD communications, and capital-structure information related to common stock and registered securities.

Proxy and governance filings cover annual meeting procedures, shareholder voting matters, board and bylaw provisions, and other corporate-governance disclosures. The record also includes amendments to bylaws, including meeting quorum and voting-requirement changes, alongside formal exhibits used to report operating results, material agreements, and other public-company events.

Rhea-AI Summary

Atomera Inc's Chief Technology Officer, Robert J. Mears, exercised stock options and sold shares in a pre-planned transaction. He exercised 10,000 Incentive Stock Options for Common Stock at $7.65 per share and then sold 8,182 Common shares at $9.46 per share, both on June 15, 2026, under a Rule 10b5-1 trading plan.

Following these transactions, Mears holds 272,715 Common shares directly and 2,666 Common shares indirectly through his spouse. The exercised option grant is now fully used, with 0 derivative shares remaining from that option.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Atomera Inc CFO Laurencio Francis reported option exercises and share sales in Atomera Inc (ATOM) stock. On June 15, 2026, he exercised incentive stock options to acquire a total of 20,400 shares of common stock at exercise prices of $7.01, $5.64, and $3.90 per share. On the same date, he sold 20,400 common shares in open-market transactions at $9.44 per share. After these transactions, Francis directly held 253,353 shares of Atomera common stock, indicating an exercise-and-sell pattern that leaves him with a substantial remaining equity position.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Atomera Inc CEO and President Scott A. Bibaud exercised options for 50,000 shares of common stock at $7.01 per share and on the same day sold 50,000 shares in an open-market transaction at $9.37 per share. Following these transactions, he directly owns 695,761 common shares and holds 179,996 non-qualified stock options expiring on March 20, 2027.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Scott A. Bibaud submitted a Form 144 notice reporting the proposed sale of 50,000 shares of Common Stock through a stock option exercise to be effected on 06/15/2026. The filing also records a prior disposition of 13,980 shares on 06/01/2026 for $133,053.55.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

ATOM notice of proposed sale: Robert Mears reported recent open-market sales and a planned stock-option-related sale. The filing lists three past sales totaling $516,317.24 and a separate stock option exercise transaction designated as Cash on 06/15/2026.

The entries show sales on 06/01/2026 (5,453 shares for $51,895.57), 06/08/2026 (37,156 shares for $306,817.67), and 06/09/2026 (18,012 shares for $157,605.00). The filing identifies the broker as Morgan Stanley Smith Barney LLC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Summary

ATOM: A Form 144 notice reports a proposed sale related to a stock option exercise of 20,400 shares dated 06/15/2026. The filing lists a prior sale on 06/01/2026 of 6,610 shares for $62,900.30. The filing identifies the broker Morgan Stanley Smith Barney LLC and names Francis Laurencio in the transaction list.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Atomera Inc Chief Technology Officer Robert J. Mears reported a series of option exercises and open-market share sales in Atomera common stock. On June 8–9, 2026, he exercised options to acquire a total of 48,115 shares at exercise prices of $7.01 and $7.65 per share, then sold 55,168 shares in multiple open-market transactions at prices between $8.20 and $8.75 per share. The filing notes that both the option exercises and the sales were carried out under a pre-arranged Rule 10b5-1 trading plan, indicating these trades were scheduled in advance rather than timed discretionarily.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 registering 18,012 shares of Common Stock for sale following a Stock Option Exercise. The filing lists the method as Cash and identifies the issuer market as NASDAQ.

Related reported sales by Robert Mears include 37,156 shares on 06/08/2026 for $306,817.67 and 5,453 shares on 06/01/2026 for $51,895.57.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Rule 144 notice of proposed sale by a holder of Common Stock of ATOM. The filing lists a Stock Option Exercise of 26,176 shares dated 06/08/2026 and prior issuer transactions: 1,000 exercised shares dated 03/02/2021 and 9,980 restricted shares dated 03/01/2026. The filing also reports a sale by Robert Mears of 5,453 shares on 06/01/2026 for $51,895.57.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Atomera Inc CEO Scott A. Bibaud reported tax-related share sales. On June 1, 2026, he sold a total of 13,980 shares of Atomera common stock in four transactions at $9.52 per share. According to the footnote, these sales were executed solely to cover tax withholding obligations arising from the vesting of previously granted restricted stock, through a mandatory, non-discretionary “sell to cover” arrangement under Rule 10b5-1(c)(1)(ii)(D)(3). After these transactions, he directly holds 695,761 shares of Atomera common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Atomera (ATOM) SEC filings are available on StockTitan?

StockTitan tracks 56 SEC filings for Atomera (ATOM), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Atomera (ATOM)?

The most recent SEC filing for Atomera (ATOM) was filed on June 18, 2026.